Hartline Investment Corp Pfizer Inc Transaction History

Hartline Investment Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$25.26 - $29.6 $1.5 Million - $1.75 Million	-59,204 Reduced 89.18%	7,180 $200,000
Q1 2024 Apr 30, 2024	BUY	$25.89 - $29.73 $1.72 Million - $1.97 Million	66,384 New	66,384 $1.84 Million
Q3 2022 Nov 01, 2022	BUY	$43.76 - $53.42 $516,280 - $630,249	11,798 New	11,798 $516,000
Q2 2019 Aug 08, 2019	SELL	$36.98 - $41.52 $190,114 - $213,454	-5,141 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $197,774 - $225,484	5,141 New	5,141 $224,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Hartline Investment Corp, based on Form 13F filings with the SEC.

Stay updated on Hartline Investment Corp with notifications on news.